Product

Anti-HIV Agents

2 clinical trials

9 indications

Indication
HIV Infection
Indication
HIV
Indication
Hepatitis B
Indication
Fibrosis
Indication
Liver
Indication
Cirrhosis
Indication
Hepatitis D
Clinical trial
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
Status: Withdrawn, Estimated PCD: 2023-08-17
Clinical trial
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients: a Long-term Prospective Cohort Study
Status: Active (not recruiting), Estimated PCD: 2024-08-01